FDA Approves Third Drug in BD Simplist Prefilled Injectable Line

FRANKLIN LAKES, N.J. /PRNewswire--BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company) announced today that the U.S. Food and Drug Administration has approved the third drug to be offered in the new BD Simplist line of ready-to-administer prefilled generic injectables.

Pharmalucence and Bosch Packaging Technology to Host Injectable Drug Manufacturing Event

Pharmalucence and Bosch Packaging Technology are hosting "Innovation Symposium 2013 on Injectable Drug Manufacturing" March 11-13 at the Burlington Marriott Hotel in Burlington, MA. Developed to address the needs of pharmaceutical manufacturing professionals, the symposium will provide the latest industry information and case studies on injectable pharmaceuticals. 

Joining Pharmalucence and Bosch Packaging Technology are IMA Life North America, Millipore, Sartorius, and IPS.

The agenda includes the following: 

Novo Nordisk Promotes Four In U.S. Executive Team

Novo Nordisk announced the promotion of four corporate vice presidents to senior vice presidents on its US Executive team.

West Breaks Ground on Manufacturing Facility in India

West Pharmaceutical India Packaging Private Ltd, an indirect subsidiary of West Pharmaceutical Services, Inc. (NYSE: WST), Lionville, Pa., USA, today  hosted a ground breaking ceremony to mark the start of construction of its new compression molding facility located in Sri City, India. The plant will become part of West’s global supply chain for its pharmaceutical packaging components.
 West has a 99-year lease on 72,800 square meters of land in the Sri City Special Economic Zone (SEZ).

BD Launches New Thin-Wall Needle

BD Medical, a segment of BD (Becton, Dickinson and Company), today announced the launch of the BD Hyflow needle, a unique 27-gauge thin-wall needle designed for use with BD's prefillable syringe systems.
The optimized inner diameter of the BD Hyflow needle enables injection of highly-viscous drug formulations without the use of a larger needle that could be more painful for the patient.

Hospira Announces Recall On Over Fill Issue

Hospira, Inc. announced today it is initiating a nationwide, voluntary, user-level recall of one lot of Hydromorphone Injection, USP, 1 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject, NDC 0409-1283-31, due to two reported complaints of a single Carpuject containing more than the 1 mL labeled fill volume.
Opioid pain medications such as Hydromorphone have life-threatening consequences if overdosed.

Promoting Patient Safety through Product Quality

At Pharmapack Europe, next-generation packaging technology seeks to address drug makers’ concerns about contamination.

Speakers and exhibitors at Pharmapack Europe February 15-16 will be focusing on easing drug delivery while overcoming industry’s challenges.

Can’t Make It to Europe?

Reconstructing Reconstitution

Building on a long history of reconstitution, two companies devise a new system for sterile water for injection intended to promote ease of use and dosing.
By Mike Schaefers, West Pharmaceutical Services; and Thomas Otto, Vetter
The process of freeze-drying injectable drugs by removing water from the material and sealing the material in a vial, known as lyophilization, was developed in the mid 1930s. Since then, lyophilization has created a faster and more convenient path for many new drugs, including biologics, to reach the market.
Your rating: None Average: 4 (1 vote)

JHP Pharma Announces Chief Executive Officer Succession

JHP Pharmaceuticals announced that Stuart Hinchen would succeed Peter Jenkins as Chief Executive Officer of the company effective July 1, 2011.

Vetter Invests in Additional Lyophilization Capacity

Vetter has installed three additional state-of-the-art lyophilizers at the company’s Ravensburg, Germany Vetter South facility, nearly doubling its number of freeze-dryers. Altogether, the site will be able to produce up to 24 million lyophilized units annually, the company said in a press release.
The new equipment increases the number of lyophilizers across all Vetter facilities by 30 percent.
Syndicate content